Up-to-Date Bioinformatics

Image: Courtesy of John Wiley & Sons Bioinformatics is "hot" these days, but it's a subject that can leave many life scientists cold. Now Hoboken, NJ-based John Wiley & Sons has launched Current Protocols in Bioinformatics, the latest addition to its popular Current Protocols series. "We're trying to make bioinformatics approachable to the biologist who doesn't have much training in computational methods," says senior editor Ann Boyle. The Current Protocols format offers a convenient way

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Bioinformatics is "hot" these days, but it's a subject that can leave many life scientists cold. Now Hoboken, NJ-based John Wiley & Sons has launched Current Protocols in Bioinformatics, the latest addition to its popular Current Protocols series. "We're trying to make bioinformatics approachable to the biologist who doesn't have much training in computational methods," says senior editor Ann Boyle.

The Current Protocols format offers a convenient way to keep abreast of this rapidly growing field. Like other titles in the series, Current Protocols in Bioinformatics will be released in installments, with articles updated periodically to reflect new trends and methodologies. The first online installment appeared in August, and a full, print version of the core manual will be released at the beginning of next year, says Boyle. Chapters are organized according to biological applications, with titles like "Modeling Structure from Sequence," "Analyzing Expression Patterns," and "Comparing Large Sequence Sets."

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies